home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Genprex, Inc. - Common Stock (NQ:GNPX)

2.010 -0.010 (-0.50%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Genprex, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE ↗

January 03, 2022

We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading.

Via InvestorPlace

Why Genprex Shares Are Soaring Today ↗

January 03, 2022

Genprex Inc (NASDAQ: GNPX) is trading higher Monday after the company announced it received U.S. Food and Drug Administration Fast Track Designation (FTD) for REQORSA...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Granted Fast Track Designation for Proprietary Immunogene Therapy from FDA

January 03, 2022

Via Investor Brand Network

Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting ↗

January 03, 2022

The FDA has granted Fast Track Designation for Genprex Inc's (NASDAQ: GNPX) lead drug candidate, Reqorsa Immunogene combination therapy. The designation...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 03, 2022

Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million....

Via Benzinga

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer

January 03, 2022

From Genprex, Inc.

Via Business Wire

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO to Present in CEO Roadshow Webinar

November 16, 2021

Via Investor Brand Network

Genprex to Present in November CEO Roadshow Webinar

November 16, 2021

From Genprex, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 27, 2021

Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 20, 2021

Gainers Tenet Healthcare (NYSE:THC) stock r...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Strengthens Management Team with Strategic Appointments

September 28, 2021

Via Investor Brand Network

Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer

September 28, 2021

From Genprex, Inc.

Via Business Wire

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Two Upcoming Investor Conferences

September 20, 2021

Via Investor Brand Network

Genprex to Participate in September Investor Conferences

September 20, 2021

From Genprex, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 26, 2021

Gainers MorphoSys (NASDAQ:MOR) stock move...

Via Benzinga

Genprex to Participate in a Monthly CEO Roadshow Webinar Series

July 20, 2021

From Genprex, Inc.

Via Business Wire

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 23, 2021

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of...

Via Benzinga

Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review

June 23, 2021

From Genprex, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 18, 2021

Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million....

Via Benzinga

Genprex Announces Participation in Noble Capital Markets’ Virtual Roadshow Series

May 19, 2021

From Genprex, Inc.

Via Business Wire

Genprex to Participate in Upcoming May Investor Conferences

May 10, 2021

From Genprex, Inc.

Via Business Wire

Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer

May 06, 2021

From Genprex, Inc.

Via Business Wire

Diamond Equity Research Emerging Growth Invitational Spring 2021 Virtual Conference

May 06, 2021

- One Day Conference May 11, 2021 - 25 Minute Presenting Time Slots From 8:30am to 1:25pm EST - Presentation Times and Links Distributed for All Presenting Companies - Investors Will Be Provided Time...

From Diamond Equity Research LLC

Via AccessWire

Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer

May 05, 2021

From Genprex, Inc.

Via Business Wire

Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer

May 04, 2021

From Genprex, Inc.

Via Business Wire

Genprex to Participate in CEO Roadshow Webinar Series

April 21, 2021

From Genprex, Inc.

Via Business Wire

Genprex to Receive Inaugural “License of the Year” Award from University of Pittsburgh Innovation Institute in Recognition of Advances Made with Gene Therapy Program in Diabetes

April 20, 2021

From Genprex, Inc.

Via Business Wire

Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting

April 12, 2021

From Genprex, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com